LEVENTON   Report issue

For profit Phase 4
Founded: Barcelona Spain (1979)
Status: No NME R&D (1979)

Organization Overview

First Clinical Trial
2017
NCT03502642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

LEVENTON